These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

798 related articles for article (PubMed ID: 33933499)

  • 41. Effects of home confinement during COVID-19 outbreak on glycemic control in patients with type 2 diabetes receiving telemedicine support.
    Scoccimarro D; Giove G; Silverii A; Dicembrini I; Mannucci E
    Acta Diabetol; 2022 Feb; 59(2):281-284. PubMed ID: 34773181
    [No Abstract]   [Full Text] [Related]  

  • 42. Impact of lockdown in COVID 19 on glycemic control in patients with type 1 Diabetes Mellitus.
    Verma A; Rajput R; Verma S; Balania VKB; Jangra B
    Diabetes Metab Syndr; 2020; 14(5):1213-1216. PubMed ID: 32679527
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The impact of strict COVID-19 lockdown in Spain on glycemic profiles in patients with type 1 Diabetes prone to hypoglycemia using standalone continuous glucose monitoring.
    Mesa A; Viñals C; Pueyo I; Roca D; Vidal M; Giménez M; Conget I
    Diabetes Res Clin Pract; 2020 Sep; 167():108354. PubMed ID: 32739380
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Glycaemic control during the lockdown for COVID-19 in adults with type 1 diabetes: A meta-analysis of observational studies.
    Garofolo M; Aragona M; Rodia C; Falcetta P; Bertolotto A; Campi F; Del Prato S; Penno G
    Diabetes Res Clin Pract; 2021 Oct; 180():109066. PubMed ID: 34563586
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Living and working environments are important determinants of glycemic control in patients with diabetes during the COVID-19 pandemic: A retrospective observational study.
    Terakawa A; Bouchi R; Kodani N; Hisatake T; Sugiyama T; Matsumoto M; Ihana-Sugiyama N; Ohsugi M; Ueki K; Kajio H
    J Diabetes Investig; 2022 Jun; 13(6):1094-1104. PubMed ID: 35088564
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of the COVID-19 lockdown on glycaemic control in subjects with type 2 diabetes: the glycalock study.
    D'Onofrio L; Pieralice S; Maddaloni E; Mignogna C; Sterpetti S; Coraggio L; Luordi C; Guarisco G; Leto G; Leonetti F; Manfrini S; Buzzetti R
    Diabetes Obes Metab; 2021 Jul; 23(7):1624-1630. PubMed ID: 33764666
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Association of Obesity and Microvascular Complications with Glycemic Control in Patients with Type 2 Diabetes Mellitus.
    Bijelic R; Balaban J; Milicevic S; Sipka SU
    Med Arch; 2020 Feb; 74(1):14-18. PubMed ID: 32317828
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The adverse effect of the COVID-19 pandemic on health service usage among patients with type 2 diabetes in North Karelia, Finland.
    Inglin L; Wikström K; Lamidi ML; Laatikainen T
    BMC Health Serv Res; 2022 Jun; 22(1):725. PubMed ID: 35650580
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Glycemic control metrics using flash glucose monitoring and hospital complications in patients with COVID-19.
    Gómez AM; Henao DC; Muñoz OM; Aschner P; Yepes CA; Jojoa R; Kerguelen A; Parra D; Jaramillo P; Umpierrez GE
    Diabetes Metab Syndr; 2021; 15(2):499-503. PubMed ID: 33662836
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of glycemic control and related factors among outpatients with type 2 diabetes at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia: a cross-sectional study.
    Abera RG; Demesse ES; Boko WD
    BMC Endocr Disord; 2022 Mar; 22(1):54. PubMed ID: 35249547
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impact of COVID-19 lockdown on glucemic control in children and adolescents with type 1 diabetes mellitus.
    Sánchez Conejero M; González de Buitrago Amigo J; Tejado Bravo ML; de Nicolás Jiménez JM
    An Pediatr (Engl Ed); 2022 Jul; 97(1):22-29. PubMed ID: 35725820
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Managing type 2 diabetes mellitus during COVID-19 pandemic: The bittersweet.
    Yehya A; Carbone S
    Diabetes Metab Res Rev; 2021 Jan; 37(1):e3360. PubMed ID: 32488991
    [No Abstract]   [Full Text] [Related]  

  • 53. The Effects of COVID-19 Lockdown on Glycaemic Control and Lipid Profile in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis.
    Ojo O; Wang XH; Ojo OO; Orjih E; Pavithran N; Adegboye ARA; Feng QQ; McCrone P
    Int J Environ Res Public Health; 2022 Jan; 19(3):. PubMed ID: 35162117
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of COVID-19 lockdown on glycemic control in children and adolescents.
    Al Agha AE; Alharbi RS; Almohammadi OA; Yousef SY; Sulimani AE; Alaama RA
    Saudi Med J; 2021 Jan; 42(1):44-48. PubMed ID: 33399170
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impact of COVID-19 lockdown on glycemic control in patients with type 1 and type 2 diabetes mellitus: a systematic review.
    Eberle C; Stichling S
    Diabetol Metab Syndr; 2021 Sep; 13(1):95. PubMed ID: 34493317
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Impact of COVID-19 Pandemic Lockdown on the Incidence of New-Onset Type 1 Diabetes and Ketoacidosis Among Saudi Children.
    Alaqeel A; Aljuraibah F; Alsuhaibani M; Huneif M; Alsaheel A; Dubayee MA; Alsaedi A; Bakkar A; Alnahari A; Taha A; Alharbi K; Alanazi Y; Almadhi S; Khalifah RA
    Front Endocrinol (Lausanne); 2021; 12():669302. PubMed ID: 33868185
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Relationship between daily and visit-to-visit glycemic variability in patients with type 2 diabetes.
    Tsuchiya T; Saisho Y; Murakami R; Watanabe Y; Inaishi J; Itoh H
    Endocr J; 2020 Aug; 67(8):877-881. PubMed ID: 32389920
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Improvement in glycaemic control in paediatric and young adult type 1 diabetes patients during COVID-19 pandemic: role of telemedicine and lifestyle changes.
    Lazzeroni P; Motta M; Monaco S; Laudisio SR; Furoncoli D; Maffini V; Rubini M; Tchana B; Ruberto C; Dodi I; Iovane B
    Acta Biomed; 2021 Nov; 92(5):e2021399. PubMed ID: 34738562
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effects of professional continuous glucose monitoring as an adjuvant educational tool for improving glycemic control in patients with type 2 diabetes.
    Rivera-Ávila DA; Esquivel-Lu AI; Salazar-Lozano CR; Jones K; Doubova SV
    BMC Endocr Disord; 2021 Apr; 21(1):79. PubMed ID: 33888117
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impact of gender differences on lifestyle and glycemic control in Japanese patients with diabetes during COVID-19 lockdowns.
    Shikuma J; Nagai Y; Sakurai M; Udagawa K; Ito R; Miwa T; Suzuki R
    Prim Care Diabetes; 2022 Jun; 16(3):350-354. PubMed ID: 35283067
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.